In The News
March 10, 2012
Senior fellow Andrew Von Eschenbach calls for a modernized Food and Drug Administration that can rapidly and efficiently bring new discoveries to patients, in a Wall Street Journal op-ed. He reminds us that the biomedical industry employs 1.2 million people, one of many facts found in "The Global Biomedical Industry: Preserving U.S. Leadership."
February 04, 2012
In this article from Foreign Policy, Senior Fellow Peter Passell probes the question of why stories of countries "blessed" with big natural resource endowments rarely have happy endings.
February 01, 2012
Milken Institute Senior Fellow Phillip Swagel recently testified at a Senate Banking Committee Hearing on the existence and regulation of "Too Big to Fail" financial institutions. Swagel offered his views on increased capital requirements, shareholder exposure, and the Volcker Rule. Related to this testimony, Yahoo! Finance's Daily Ticker interviewed Swagel for additional insights on "Too Big to Fail" institutions and reform of the GSEs, and also interviewed him on the European financial crisis.
December 04, 2011
Asking, "Why block a test that saves lives?" Institute chairman Michael Milken points out in an Op-Ed appearing in the Washington Post the importance of prostate cancer screening, challenging recent recommendations from the U.S. Preventive Services Task Force that healthy men not receive prostate-specific antigen (PSA) tests.
December 03, 2011
In "Greece's Unpleasant Arithmetic: Containing the Threat to the Global Economy," Milken Institute economists explore how a country that accounts for less than one fifth of one percent of the world population, and less than half of one percent of global GDP, has the potential to trigger a global recession. Despite its tiny size, Greece is edging ever closer to severely disrupting global financial and economic markets, unless decisive corrective action is taken.
Displaying records 541-545 out of 545
